v3.26.1
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]    
Revenue $ 63,777
Cost of goods sold 956,160 6,650,979
Gross loss (956,160) (6,587,202)
Operating expenses:    
Research and development 1,394,905 1,493,202
Sales and marketing 990,471
General and administrative 8,104,834 8,646,301
Loss on impairment of long-lived assets 1,659,835
Total operating expenses 9,499,739 12,789,809
Loss from operations (10,455,899) (19,377,011)
Other income (expense):    
Interest income 126,620 484,325
Change in fair value - warrant liability (11,627,100) 10,956,900
Change in fair value - derivative liability 2,854,000 6,739,000
Unrealized loss on digital assets (2,151,001)
Unrealized gain (loss) on marketable securities (91,936) (98,315)
Realized gain on marketable securities 409,818 1,322,971
Legal settlement (1,096,222)
Vendor settlement (647,833)
Consent and waiver fee - Series H-7 (350,000)
Other income (expense), net 196,353 (39,294)
Total other income (expense), net (10,633,246) 17,621,532
Net income (loss) prior to provision for income taxes (21,089,145) (1,755,479)
Provision for income taxes
Net income (loss) (21,089,145) (1,755,479)
Dividends earned on Series H-7 convertible preferred stock (1,997,443) (2,425,599)
Accretion of discounts to redemption value of Series H-7 convertible preferred stock (5,131,858) (8,255,150)
Net loss attributable to common stockholders $ (28,218,446) $ (12,436,228)
Net loss per share basic $ (32.24) $ (32.25)
Net loss per share diluted $ (32.24) $ (32.25)
Basic weighted average Common Stock outstanding 875,190 385,652
Diluted weighted average Common Stock outstanding 875,190 385,652

Source

PDF HTML
ZIP XBRL